论文部分内容阅读
目的评价肝门部胆管癌所致梗阻性黄疸的介入治疗方法。方法64例肝门部胆管癌患者共行经皮肝穿胆道引流术(PTCD)51例,胆道内涵管植入术25例,胆道金属内支架植入术33例。观察其引流前后血清总胆红素(TBIL)变化、并发症发生情况及生存期。结果术前TBIL平均为172.4mmol/L,术后76.9mmol/L,介入治疗前后有明显差异(P<0.01)。近期并发症有胸腹腔出血3例,十二指肠穿孔1例,胆道感染5例。远期并发症为术后3月再狭窄12例。患者平均生存期173.7天。结论应根据梗阻性黄疸具体特征合理及综合选择不同介入治疗方法。
Objective To evaluate the interventional treatment of obstructive jaundice caused by hilar cholangiocarcinoma. Methods Totally 64 cases of hilar cholangiocarcinoma were treated with percutaneous transhepatic biliary drainage (PTCD) in 51 cases, biliary tracheal implantation in 25 cases and biliary metal stent implantation in 33 cases. To observe the changes of serum total bilirubin (TBIL) before and after drainage, complications and survival. Results The mean preoperative TBIL was 172.4mmol / L and postoperative 76.9mmol / L, with significant difference before and after intervention (P <0.01). Recent complications were thoracic and abdominal bleeding in 3 cases, 1 case of duodenal perforation, 5 cases of biliary tract infection. Long-term complications of restenosis in March after 12 cases. The average survival time of patients was 173.7 days. Conclusions should be based on the specific characteristics of obstructive jaundice reasonable and comprehensive selection of different interventional methods.